These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 31950981)

  • 1. Structural dynamics and allostery of Rab proteins: strategies for drug discovery and design.
    Kumar AP; Verma CS; Lukman S
    Brief Bioinform; 2021 Jan; 22(1):270-287. PubMed ID: 31950981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computational Tools for Allosteric Drug Discovery: Site Identification and Focus Library Design.
    Huang W; Nussinov R; Zhang J
    Methods Mol Biol; 2017; 1529():439-446. PubMed ID: 27914066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using two-dimensional convolutional neural networks for identifying GTP binding sites in Rab proteins.
    Le NQK; Ho QT; Ou YY
    J Bioinform Comput Biol; 2019 Feb; 17(1):1950005. PubMed ID: 30866734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allosteric binding sites in Rab11 for potential drug candidates.
    Kumar AP; Lukman S
    PLoS One; 2018; 13(6):e0198632. PubMed ID: 29874286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HPC Analysis of Multiple Binding Sites Communication and Allosteric Modulations in Drug Design: The HSP Case Study.
    Chiappori F; Milanesi L; Merelli I
    Curr Drug Targets; 2016; 17(14):1610-1625. PubMed ID: 26648062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The mammalian Rab family of small GTPases: definition of family and subfamily sequence motifs suggests a mechanism for functional specificity in the Ras superfamily.
    Pereira-Leal JB; Seabra MC
    J Mol Biol; 2000 Aug; 301(4):1077-87. PubMed ID: 10966806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are the Apo Proteins Suitable for the Rational Discovery of Allosteric Drugs?
    An X; Lu S; Song K; Shen Q; Huang M; Yao X; Liu H; Zhang J
    J Chem Inf Model; 2019 Jan; 59(1):597-604. PubMed ID: 30525607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progressive computational approaches to facilitate decryption of allosteric mechanism and drug discovery.
    Lu X; Lan X; Lu S; Zhang J
    Curr Opin Struct Biol; 2023 Dec; 83():102701. PubMed ID: 37716092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding G Protein-Coupled Receptor Allostery via Molecular Dynamics Simulations: Implications for Drug Discovery.
    Basith S; Lee Y; Choi S
    Methods Mol Biol; 2018; 1762():455-472. PubMed ID: 29594786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allosteric Methods and Their Applications: Facilitating the Discovery of Allosteric Drugs and the Investigation of Allosteric Mechanisms.
    Lu S; Shen Q; Zhang J
    Acc Chem Res; 2019 Feb; 52(2):492-500. PubMed ID: 30688063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of hidden allosteric sites as novel targets for allosteric drug design.
    Lu S; Ji M; Ni D; Zhang J
    Drug Discov Today; 2018 Feb; 23(2):359-365. PubMed ID: 29030241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploiting protein flexibility to predict the location of allosteric sites.
    Panjkovich A; Daura X
    BMC Bioinformatics; 2012 Oct; 13():273. PubMed ID: 23095452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opportunities and Challenges in the Discovery of Allosteric Modulators of GPCRs.
    Bartuzi D; Kaczor AA; Matosiuk D
    Methods Mol Biol; 2018; 1705():297-319. PubMed ID: 29188568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Harnessing allostery: a novel approach to drug discovery.
    Lu S; Li S; Zhang J
    Med Res Rev; 2014 Nov; 34(6):1242-85. PubMed ID: 24827416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polyphony: superposition independent methods for ensemble-based drug discovery.
    Pitt WR; Montalvão RW; Blundell TL
    BMC Bioinformatics; 2014 Sep; 15(1):324. PubMed ID: 25265915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing the structural conservation of protein pockets to study functional and allosteric sites: implications for drug discovery.
    Panjkovich A; Daura X
    BMC Struct Biol; 2010 Mar; 10():9. PubMed ID: 20356358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allosteric sites can be identified based on the residue-residue interaction energy difference.
    Ma X; Qi Y; Lai L
    Proteins; 2015 Aug; 83(8):1375-84. PubMed ID: 25185787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging computational approaches for the study of protein allostery.
    Collier G; Ortiz V
    Arch Biochem Biophys; 2013 Oct; 538(1):6-15. PubMed ID: 23933229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current and Future Challenges in GPCR Drug Discovery.
    Topiol S
    Methods Mol Biol; 2018; 1705():1-21. PubMed ID: 29188556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of Rab1 binding sites using an ensemble of clustering methods.
    Lukman S; Nguyen MN; Sim K; Teo JC
    Proteins; 2017 May; 85(5):859-871. PubMed ID: 28120477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.